130 related articles for article (PubMed ID: 8611436)
1. Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.
Ho S; Cheng P; Yuen J; Chan A; Leung N; Yeo W; Leung T; Lau WY; Li AK; Johnson PJ
Br J Cancer; 1996 Apr; 73(8):985-8. PubMed ID: 8611436
[TBL] [Abstract][Full Text] [Related]
2. Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing.
Burditt LJ; Johnson MM; Johnson PJ; Williams R
Cancer; 1994 Jul; 74(1):25-9. PubMed ID: 7516264
[TBL] [Abstract][Full Text] [Related]
3. Germ cell tumors express a specific alpha-fetoprotein variant detectable by isoelectric focusing.
Johnson PJ; Ho S; Cheng P; Chan A; Leung T; Yuen J
Cancer; 1995 Apr; 75(7):1663-8. PubMed ID: 8826925
[TBL] [Abstract][Full Text] [Related]
4. Serum ferritin in hepatocellular carcinoma. A comparison with alphafetoprotein.
Melia WM; Bullock S; Johnson PJ; Williams R
Cancer; 1983 Jun; 51(11):2112-5. PubMed ID: 6188526
[TBL] [Abstract][Full Text] [Related]
5. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
[TBL] [Abstract][Full Text] [Related]
6. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
[TBL] [Abstract][Full Text] [Related]
7. 'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease.
Johnson PJ; Leung N; Cheng P; Welby C; Leung WT; Lau WY; Yu S; Ho S
Br J Cancer; 1997; 75(2):236-40. PubMed ID: 9010032
[TBL] [Abstract][Full Text] [Related]
8. Alphafetoprotein: an obituary.
Sherman M
J Hepatol; 2001 Apr; 34(4):603-5. PubMed ID: 11394662
[No Abstract] [Full Text] [Related]
9. Comparison of various assays for detection of AFP in differentiating patients with primary hepatocellular carcinoma from controls.
Chan SH; Heng SH; Yo SL; Oon CJ
J Clin Pathol; 1980 Aug; 33(8):792-3. PubMed ID: 6159370
[TBL] [Abstract][Full Text] [Related]
10. [Echographic detection of hepatocellular carcinoma in patients hospitalized for cirrhosis].
Roget L; Coppéré H; Richard P; Barthélém C; Veyret C; Audigier JC
Gastroenterol Clin Biol; 1988 Nov; 12(11):827-32. PubMed ID: 2464520
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Clinical Utility of Glypican 3 as a Serum Marker for the Diagnosis of Hepatocellular Carcinoma.
Jia X; Gao Y; Zhai D; Liu J; Cai J; Wang Y; Jing L; Du Z
Technol Cancer Res Treat; 2016 Dec; 15(6):780-786. PubMed ID: 26370140
[TBL] [Abstract][Full Text] [Related]
12. [Alpha-fetoprotein: diagnostic value in hepatic disorders].
Kreczko S; Lipska A; Wysocka J
Pol Merkur Lekarski; 2000 Jun; 8(48):420-3. PubMed ID: 10967924
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma. Identifying and screening populations at increased risk.
Smith CS; Paauw DS
Postgrad Med; 1993 Dec; 94(8):71-4. PubMed ID: 7504252
[TBL] [Abstract][Full Text] [Related]
14. [Relation between serum markers of hepatitis B virus and alpha fetoprotein in hepatocellular carcinoma in France].
Attali P; Prod'homme S; Pelletier G; Papoz L; Buffet C; Etienne JP
Gastroenterol Clin Biol; 1986 Oct; 10(10):637-40. PubMed ID: 2431948
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis].
Lee HY; Jung JH; Kang YS; Kim YS; Moon HS; Park KO; Lee YS; Kim SM; Seo SW; Lee SW; Kim SH; Lee BS; Kim NJ
Korean J Gastroenterol; 2004 Apr; 43(4):252-9. PubMed ID: 15100489
[TBL] [Abstract][Full Text] [Related]
16. Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.
Johnson PJ; Portmann B; Williams R
Br Med J; 1978 Sep; 2(6138):661-3. PubMed ID: 81086
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.
Oka H; Tamori A; Kuroki T; Kobayashi K; Yamamoto S
Hepatology; 1994 Jan; 19(1):61-6. PubMed ID: 7506227
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
[TBL] [Abstract][Full Text] [Related]
20. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
